| |
| |
|
| Insider
Information: |
Camber Capital Management Llc |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
34,354,918 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$54,233,565 |
|
|
| Total
Shares |
34,354,918 |
|
|
| Total
Value |
$54,233,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 0.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
World Heart Corp |
WHRT |
10% Owner |
|
0 |
2012-08-02 |
4,918 |
Premium* |
|
|
Sequenom Inc |
SQNM |
10% Owner |
2015-10-06 |
0 |
2016-01-04 |
17,325,000 |
Premium* |
|
|
Protalix Biotherapeutics |
PLX |
10% Owner |
2015-10-19 |
0 |
2016-12-02 |
10,775,000 |
Premium* |
|
|
Replidyne Inc |
RDYN |
10% Owner |
|
0 |
2016-09-20 |
3,000,000 |
Premium* |
|
|
AMAG Pharmaceuticals Inc |
AMAG |
|
|
0 |
2020-10-01 |
0 |
Premium* |
|
|
Zimvie Inc. |
ZIMV |
|
|
0 |
2023-03-17 |
3,250,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZIMV |
Zimvie Inc. |
|
– – • |
2023-03-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,250,000 |
|
% |
|
| AMAG |
AMAG Pharmaceuticals Inc |
|
• • • |
2020-10-01 |
4 |
S |
$13.57 |
$59,586,787 |
I/I |
(4,390,000) |
0 |
0 |
% |
|
| AMAG |
AMAG Pharmaceuticals Inc |
|
• • • |
2019-08-09 |
4 |
B |
$8.94 |
$268,996 |
I/I |
30,000 |
4,390,000 |
0.01 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
|
• • • |
2019-08-07 |
4 |
B |
$7.58 |
$2,760,796 |
I/I |
355,000 |
4,360,000 |
0.01 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
|
– – • |
2019-07-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,005,000 |
|
- |
|
| PLX |
Protalix Biotherapeutics |
10% Owner |
• • • |
2016-12-02 |
4 |
S |
$0.32 |
$792,000 |
I/I |
(2,500,000) |
10,775,000 |
0 |
- |
|
| RDYN |
Replidyne Inc |
10% Owner |
• • • |
2016-09-20 |
4 |
S |
$23.54 |
$1,341,643 |
I/I |
(57,000) |
3,000,000 |
0 |
- |
|
| RDYN |
Replidyne Inc |
10% Owner |
• • • |
2016-09-19 |
4 |
S |
$23.25 |
$24,249,854 |
I/I |
(1,043,000) |
3,057,000 |
0 |
- |
|
| RDYN |
Replidyne Inc |
10% Owner |
– – • |
2016-02-23 |
4 |
B |
$7.55 |
$1,888,725 |
I/I |
250,000 |
4,100,000 |
1.5 |
- |
|
| RDYN |
Replidyne Inc |
10% Owner |
– – • |
2016-01-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,850,000 |
|
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2016-01-04 |
4 |
B |
$1.59 |
$119,250 |
I/I |
75,000 |
17,325,000 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-12-31 |
4 |
B |
$1.64 |
$648,553 |
I/I |
395,435 |
17,250,000 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-12-30 |
4 |
B |
$1.59 |
$310,596 |
I/I |
195,000 |
16,854,565 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-12-16 |
4/A |
B |
$1.41 |
$28,188 |
I/I |
20,000 |
16,659,565 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-12-15 |
4 |
B |
$1.41 |
$28,180 |
I/I |
20,000 |
16,659,565 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-12-14 |
4 |
B |
$1.26 |
$581,557 |
I/I |
448,000 |
16,639,565 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-12-10 |
4 |
B |
$1.36 |
$344,088 |
I/I |
253,565 |
16,191,565 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-12-09 |
4 |
B |
$1.32 |
$281,586 |
I/I |
213,000 |
15,938,000 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-12-08 |
4 |
B |
$1.24 |
$401,375 |
I/I |
325,000 |
15,275,000 |
1.5 |
- |
|
| PLX |
Protalix Biotherapeutics |
10% Owner |
– – • |
2015-10-19 |
4 |
B |
$1.00 |
$4,000,436 |
I/I |
4,000,423 |
13,275,000 |
1.5 |
- |
|
| PLX |
Protalix Biotherapeutics |
10% Owner |
– – • |
2015-10-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,274,577 |
|
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-10-08 |
4 |
B |
$2.00 |
$1,164,494 |
I/I |
562,328 |
15,400,000 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-10-07 |
4 |
B |
$1.98 |
$322,344 |
I/I |
162,718 |
14,837,762 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-10-06 |
4 |
B |
$1.89 |
$1,755,166 |
I/I |
925,044 |
14,675,044 |
1.5 |
- |
|
| SQNM |
Sequenom Inc |
10% Owner |
– – • |
2015-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
13,750,000 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
